Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 17/20 | 0.43 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.42 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.39 |
| ▸ | ZAP70 | P43403 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | JAK2 | O60674 | 1/20 | 0.37 |
| ▸ | JAK3 | P52333 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1847356 | 0.89 | SYK (0.42) | SYK | |
| SCHEMBL1849097 | 0.75 | SYK (0.64) | SYK | |
| SCHEMBL13723345 | 0.75 | ADORA1 (0.57) | SYKTLR8AURKBZAP70KCNH2 | |
| SCHEMBL1352415 | 0.74 | SYK (0.60) | SYKAURKBZAP70KCNH2 | |
| SCHEMBL1352413 | 0.74 | SYK (0.60) | SYKAURKBZAP70KCNH2 | |
| SCHEMBL14976274 | 0.72 | SYK (0.58) | SYKAURKBZAP70KCNH2 | |
| SCHEMBL1849939 | 0.72 | SYK (0.63) | SYKAURKBZAP70KCNH2 | |
| SCHEMBL14976276 | 0.72 | SYK (0.58) | SYKAURKBZAP70KCNH2 | |
| SCHEMBL1849946 | 0.72 | SYK (0.63) | SYKAURKBZAP70KCNH2 | |
| SCHEMBL1848253 | 0.72 | SYK (0.57) | SYKAURKBZAP70KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2323993-A2 | 2,6-DIAMINO- PYRIMIDIN- 5-YL-CARBOXAMIDES AS SYK OR JAK KINASES INHIBITORS | Portola Pharmaceuticals, Inc. (US) | 2011-05-25 | — | — | EP | disclosed |
| WO-2009136995-A2 | INHIBITORS OF SYK PROTEIN KINASE | PORTOLA PHARMACEUTICALS, INC. (US) | 2009-11-12 | — | — | WO | disclosed |